Suppr超能文献

磁共振波谱引导下的脑肿瘤切除术:两例诊断困难病例中复发性胶质瘤与放射性改变的鉴别

Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.

作者信息

Preul M C, Leblanc R, Caramanos Z, Kasrai R, Narayanan S, Arnold D L

机构信息

Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, Quebec, Canada.

出版信息

Can J Neurol Sci. 1998 Feb;25(1):13-22. doi: 10.1017/s0317167100033436.

Abstract

BACKGROUND

It is often difficult to differentiate a recurrent glioma from the effects of post-operative radiotherapy by means of conventional neurodiagnostic imaging. Proton magnetic resonance spectroscopic imaging (1H-MRSI), that allows in vivo measurements of the concentration of brain metabolites such as choline-containing phospholipids (Cho), may provide in vivo biochemical information helpful in distinguishing areas of tumor recurrence from areas of radiation effect.

PATIENTS AND METHODS

Two patients who had undergone resection and post-operative radiotherapy for a cerebral glioma became newly symptomatic. Computed tomographic (CT) and magnetic resonance imaging (MRI) performed after the intravenous infusion of contrast material, and in one case, [18F]fluorodeoxyglucose positron emission tomography (PET), could not differentiate between the possibilities of recurrent glioma and radiation effect. The patients underwent 1H-MRSI prior to reoperation and the 1H-MRSI results were compared to histological findings originating from the same locations.

RESULTS

A high Cho signal measured by 1H-MRSI was seen in areas of histologically-proven dense tumor recurrence, while low Cho signal was present where radiation changes predominated.

CONCLUSIONS

The differentiation between the recurrence of a cerebral glioma and the effects of post-operative irradiation was achieved using 1H-MRSI in these two patients whose conventional neurodiagnostic imaging was equivocal for such a distinction. Where these two conditions are present, metabolite images from 1H-MRSI, such as that based on Cho, can be co-registered with other imaging modalities such as MRI and may also be integrated with functional MRI or functional PET within a multimodal imaging-guided surgical navigation system to assure maximal resection of recurrent tumor while minimizing the risk of added neurological damage.

摘要

背景

通过传统的神经诊断成像手段,往往难以区分复发性胶质瘤与术后放疗的影响。质子磁共振波谱成像(1H-MRSI)能够在体内测量脑代谢物的浓度,如含胆碱磷脂(Cho),可为区分肿瘤复发区域和放疗影响区域提供有用的体内生化信息。

患者与方法

两名接受过脑胶质瘤切除及术后放疗的患者出现了新的症状。静脉注射造影剂后进行的计算机断层扫描(CT)和磁共振成像(MRI),以及在其中一例中进行的[18F]氟脱氧葡萄糖正电子发射断层扫描(PET),均无法区分复发性胶质瘤和放疗影响的可能性。患者在再次手术前接受了1H-MRSI检查,并将1H-MRSI结果与来自相同部位的组织学检查结果进行了比较。

结果

在组织学证实的密集肿瘤复发区域,1H-MRSI测量到高Cho信号,而在以放疗改变为主的区域则出现低Cho信号。

结论

在这两名传统神经诊断成像对此区分不明确的患者中,使用1H-MRSI实现了脑胶质瘤复发与术后放疗影响的区分。在存在这两种情况时,来自1H-MRSI的代谢物图像,如基于Cho的图像,可与MRI等其他成像模态进行配准,也可在多模态成像引导的手术导航系统中与功能MRI或功能PET整合,以确保在将新增神经损伤风险降至最低的同时,最大程度地切除复发性肿瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验